Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pyridostigmine in HIV-1 Infected Patients with Incomplete Immune Response to HAART
NCT00518154Phase 2Completed
- Sponsor
- Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán
- Start
- Sep 2007
- Primary completion
- Nov 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pyridostigmine in human immunodeficiency virus infection (HIV), sponsored by Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán. Started Sep 2007; status: completed.
02
Drugs
pyridostigmine
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00518154.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00518154.